Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases

Nucleic Acids Res. 2020 Apr 17;48(7):3722-3733. doi: 10.1093/nar/gkaa110.

Abstract

The widespread use of Cas12a (formerly Cpf1) nucleases for genome engineering is limited by their requirement for a rather long TTTV protospacer adjacent motif (PAM) sequence. Here we have aimed to loosen these PAM constraints and have generated new PAM mutant variants of the four Cas12a orthologs that are active in mammalian and plant cells, by combining the mutations of their corresponding RR and RVR variants with altered PAM specificities. LbCas12a-RVRR showing the highest activity was selected for an in-depth characterization of its PAM preferences in mammalian cells, using a plasmid-based assay. The consensus PAM sequence of LbCas12a-RVRR resembles a TNTN motif, but also includes TACV, TTCV CTCV and CCCV. The D156R mutation in improved LbCas12a (impLbCas12a) was found to further increase the activity of that variant in a PAM-dependent manner. Due to the overlapping but still different PAM preferences of impLbCas12a and the recently reported enAsCas12a variant, they complement each other to provide increased efficiency for genome editing and transcriptome modulating applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Associated Proteins / genetics*
  • CRISPR-Associated Proteins / metabolism*
  • Cell Line, Tumor
  • Endodeoxyribonucleases / genetics*
  • Endodeoxyribonucleases / metabolism*
  • Gene Editing*
  • HEK293 Cells
  • Humans
  • Mice
  • Mutation
  • Substrate Specificity

Substances

  • CRISPR-Associated Proteins
  • Endodeoxyribonucleases